Evaluating oral selexipag in PAH: Insights on survival, safety and dosing patterns from the complete observation period of GRIPHON and its open-label extension
Related Posts
Chen M, Ding N, Wang FM, Obisesan OH, Folsom AR, Howard-Claudio CM, Budoff M, Blaha MJ, Matsushita K. Associations of cigarette smoking with coronary artery[...]
Capone F, Häseli SP, Liu L, Strocchi S, Langenberg C, Lusis AJ, Pietzner M, Muoio DM, Rider OJ, Raman B, Fudim M, Romeo S, Wang[...]
We are pleased to announce the appointment of James S. Lee, MD as the new community clinical chief of cardiology in the UCLA Department of Medicine Division[...]